- Published on
Emergency And Acute Medicine – Radiation Injury
Radiation injury refers to damage caused by ionizing radiation. Types include alpha particles, which are helium nuclei that do not penetrate skin; beta particles, which are electrons that penetrate a few centimeters into tissue; gamma rays, which are highly penetrating photons; and neutrons, which are very penetrating and not detected by standard Geiger counters, though neutron sources usually emit gamma radiation as well. A radionuclide is a radioactive element that emits radiation from its nucleus; radioactivity cannot be destroyed, only relocated or shielded, and radioactive elements retain their usual chemical properties, including heavy metal toxicity.
Exposure or irradiation means a patient has been in the presence of ionizing radiation, affecting part or all of the body. Contamination refers to radioactive material being present where it is not desired, either externally on skin, hair, or clothing, or internally within the body, such as in the lungs. Radiation dose is the amount of energy absorbed by tissue and is measured in gray (Gy) or sievert (Sv); 1 Gy equals 100 rad, and for beta and gamma radiation, 1 Gy equals 1 Sv. If a radiation incident is suspected, regional or federal authorities should be contacted immediately for guidance.
Ionizing radiation causes cellular injury and vascular damage, leading to endarteritis and impaired blood supply. Rapidly dividing tissues such as bone marrow and gastrointestinal epithelium are highly sensitive, whereas skin and nerve tissue are less sensitive. Acute radiation syndrome (ARS) follows whole-body exposure and progresses through stages. The prodromal phase occurs within 0–48 hours and includes nausea, vomiting, and inflammation. The latent phase may last up to two weeks, during which symptoms temporarily improve. The manifest illness phase involves organ failure, particularly hematopoietic, gastrointestinal, or neurovascular systems, depending on dose. Recovery or death, often from infection, follows. Sources include medical and industrial devices, therapeutic radiation, nuclear weapons, and radiologic dispersal devices.
Clinical manifestations depend on dose. Whole-body exposure resembles high-dose chemotherapy toxicity. Nausea and vomiting within 3–6 hours suggest exposure greater than 100 rad, while vomiting within 1 hour suggests potentially lethal exposure exceeding 600 rad. Confusion and weakness may occur with doses above 200 rad. Fever may reflect early inflammation or later infection. Hair loss, hemorrhage, and diarrhea occur with higher doses. Local radiation injury initially resembles a thermal burn with erythema, later progressing to blistering, ischemia, and necrosis. Suspicion should arise if multiple patients present with ARS symptoms, burns without thermal history, or unusual ischemic ulcers.
Assessment includes radiation survey with a Geiger counter. The probe should be covered with a glove to prevent contamination and moved slowly 1-2 cm from the skin at 2-3 cm per second. Background radiation should be measured first. Contamination is defined as greater than twice background levels. Palms, soles, and hair must be examined. Absolute lymphocyte count is the most useful laboratory indicator of ARS severity; counts below 1,000/mm³ suggest moderate exposure (200-600 rad), and below 500/mm³ suggest severe exposure (>600 rad). Serial complete blood counts every 4–6 hours during the first 24 hours are recommended. Cytogenetic analysis at 24 hours postexposure provides more accurate dose estimation but requires specialized facilities.
Management prioritizes airway, breathing, and circulation. Removal of clothing eliminates approximately 80% of external contamination. Emergency care takes precedence over decontamination, as no documented case shows a contaminated patient posing immediate life-threatening radiation risk to providers. Staff should use particulate respirators such as N-95 masks, gowns, gloves, and protective covers; radiography lead aprons do not protect against most gamma radiation. Decontamination focuses first on wounds, then mucous membranes, then intact skin. Gentle washing with soap and water is recommended, avoiding abrasion. Runoff should be collected and monitored. If contamination persists, the area should be covered to prevent spread.
Symptomatic treatment includes antiemetics such as ondansetron and intravenous fluids for dehydration. Potassium iodide is useful only for preventing thyroid uptake of radioactive iodine and must be given within four hours of exposure; adult dosing is 130 mg orally daily, with weight-based pediatric dosing. Cytokines and transfusions may be required for significant bone marrow suppression. Internal contamination requires radionuclide-specific decorporation therapy in consultation with radiation experts such as REAC/TS.
Admission is indicated for lymphocyte counts below 1,000/mm³ at 24–48 hours, a 50% decline in lymphocyte count, suspected exposure above 200 rad, significant trauma, or uncontrolled vomiting. Discharge may be considered if there is no residual contamination, no evidence of significant exposure, and the patient tolerates oral intake. All patients with confirmed exposure require dose assessment, counseling, and follow-up.
Children and fetuses are more sensitive to radiation effects. Potassium iodide is particularly important for children in radioactive iodine exposure. Pregnant staff should avoid caring for contaminated patients. Psychological reactions are common and may mimic ARS; a falling lymphocyte count helps distinguish true radiation injury from stress-related symptoms.
Radiation injury refers to damage caused by ionizing radiation. Types include alpha particles, which are helium nuclei that do not penetrate skin; beta particles, which are electrons that penetrate a few centimeters into tissue; gamma rays, which are highly penetrating photons; and neutrons, which are very penetrating and not detected by standard Geiger counters, though neutron sources usually emit gamma radiation as well. A radionuclide is a radioactive element that emits radiation from its nucleus; radioactivity cannot be destroyed, only relocated or shielded, and radioactive elements retain their usual chemical properties, including heavy metal toxicity.
Exposure or irradiation means a patient has been in the presence of ionizing radiation, affecting part or all of the body. Contamination refers to radioactive material being present where it is not desired, either externally on skin, hair, or clothing, or internally within the body, such as in the lungs. Radiation dose is the amount of energy absorbed by tissue and is measured in gray (Gy) or sievert (Sv); 1 Gy equals 100 rad, and for beta and gamma radiation, 1 Gy equals 1 Sv. If a radiation incident is suspected, regional or federal authorities should be contacted immediately for guidance.
Ionizing radiation causes cellular injury and vascular damage, leading to endarteritis and impaired blood supply. Rapidly dividing tissues such as bone marrow and gastrointestinal epithelium are highly sensitive, whereas skin and nerve tissue are less sensitive. Acute radiation syndrome (ARS) follows whole-body exposure and progresses through stages. The prodromal phase occurs within 0–48 hours and includes nausea, vomiting, and inflammation. The latent phase may last up to two weeks, during which symptoms temporarily improve. The manifest illness phase involves organ failure, particularly hematopoietic, gastrointestinal, or neurovascular systems, depending on dose. Recovery or death, often from infection, follows. Sources include medical and industrial devices, therapeutic radiation, nuclear weapons, and radiologic dispersal devices.
Clinical manifestations depend on dose. Whole-body exposure resembles high-dose chemotherapy toxicity. Nausea and vomiting within 3–6 hours suggest exposure greater than 100 rad, while vomiting within 1 hour suggests potentially lethal exposure exceeding 600 rad. Confusion and weakness may occur with doses above 200 rad. Fever may reflect early inflammation or later infection. Hair loss, hemorrhage, and diarrhea occur with higher doses. Local radiation injury initially resembles a thermal burn with erythema, later progressing to blistering, ischemia, and necrosis. Suspicion should arise if multiple patients present with ARS symptoms, burns without thermal history, or unusual ischemic ulcers.
Assessment includes radiation survey with a Geiger counter. The probe should be covered with a glove to prevent contamination and moved slowly 1-2 cm from the skin at 2-3 cm per second. Background radiation should be measured first. Contamination is defined as greater than twice background levels. Palms, soles, and hair must be examined. Absolute lymphocyte count is the most useful laboratory indicator of ARS severity; counts below 1,000/mm³ suggest moderate exposure (200-600 rad), and below 500/mm³ suggest severe exposure (>600 rad). Serial complete blood counts every 4–6 hours during the first 24 hours are recommended. Cytogenetic analysis at 24 hours postexposure provides more accurate dose estimation but requires specialized facilities.
Management prioritizes airway, breathing, and circulation. Removal of clothing eliminates approximately 80% of external contamination. Emergency care takes precedence over decontamination, as no documented case shows a contaminated patient posing immediate life-threatening radiation risk to providers. Staff should use particulate respirators such as N-95 masks, gowns, gloves, and protective covers; radiography lead aprons do not protect against most gamma radiation. Decontamination focuses first on wounds, then mucous membranes, then intact skin. Gentle washing with soap and water is recommended, avoiding abrasion. Runoff should be collected and monitored. If contamination persists, the area should be covered to prevent spread.
Symptomatic treatment includes antiemetics such as ondansetron and intravenous fluids for dehydration. Potassium iodide is useful only for preventing thyroid uptake of radioactive iodine and must be given within four hours of exposure; adult dosing is 130 mg orally daily, with weight-based pediatric dosing. Cytokines and transfusions may be required for significant bone marrow suppression. Internal contamination requires radionuclide-specific decorporation therapy in consultation with radiation experts such as REAC/TS.
Admission is indicated for lymphocyte counts below 1,000/mm³ at 24–48 hours, a 50% decline in lymphocyte count, suspected exposure above 200 rad, significant trauma, or uncontrolled vomiting. Discharge may be considered if there is no residual contamination, no evidence of significant exposure, and the patient tolerates oral intake. All patients with confirmed exposure require dose assessment, counseling, and follow-up.
Children and fetuses are more sensitive to radiation effects. Potassium iodide is particularly important for children in radioactive iodine exposure. Pregnant staff should avoid caring for contaminated patients. Psychological reactions are common and may mimic ARS; a falling lymphocyte count helps distinguish true radiation injury from stress-related symptoms.
0 Comments
